All In Biotech

Drug Trial Radar · NCT01114217

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Last checked: Nov 20, 2026Latest source record: Apr 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

634

Actual

Start

Jul 27, 2010

Primary completion

Sep 24, 2012

Study completion Apr 23, 2013

Sponsor

Lead sponsor
AMAG Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 3, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).

Conditions

  • Iron Deficiency Anemia

Interventions

  • FerumoxytolDrug

    IV Ferumoxytol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change In Hemoglobin From TP Baseline To TP Week 5 Following The First Course Of FerumoxytolTime frame: TP Baseline (Day 1), TP Week 5

Locations

140 sites in 6 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Birmingham, Alabama

  • Clinical Trial Site

    Mobile, Alabama

  • Clinical Trial Site

    Montgomery, Alabama

  • Clinical Trial Site

    Montgomery, Alabama

  • Clinical Trial Site

    Phoenix, Arizona

  • Clinical Trial Site

    Phoenix, Arizona

  • Clinical Trial Site

    Tucson, Arizona

  • Clinical Trial Site

    Tucson, Arizona

  • Clinical Trial Site

    Anaheim, California

  • Clinical Trial Site

    Bakersfield, California

  • Clinical Trial Site

    Buena Park, California

  • Clinical Trial Site

    Colton, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Mission Hills, California

  • Clinical Trial Site

    Orange, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    Pueblo, Colorado

  • Clinical Trial Site

    Bristol, Connecticut

  • Clinical Trial Site

    Groton, Connecticut

  • Clinical Trial Site

    Boynton Beach, Florida

  • Clinical Trial Site

    Boynton Beach, Florida

  • Clinical Trial Site

    Clearwater, Florida

  • Clinical Trial Site

    Clearwater, Florida

  • Clinical Trial Site

    Hialeah, Florida

  • Clinical Trial Site

    Holiday, Florida

  • Clinical Trial Site

    Inverness, Florida

  • Clinical Trial Site

    Margate, Florida

  • Clinical Trial Site

    Miami, Florida

  • Clinical Trial Site

    Miami, Florida

  • Clinical Trial Site

    Miami, Florida

  • Clinical Trial Site

    Miami, Florida

  • Clinical Trial Site

    Miami, Florida

  • Clinical Trial Site

    Miami Lakes, Florida

  • Clinical Trial Site

    Naples, Florida

  • Clinical Trial Site

    Vero Beach, Florida

  • Clinical Trial Site

    West Palm Beach, Florida

Showing 40 of 140 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.